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Licorice is commonly used as a cure for digestive disorders and as a detoxification agent in East
Asia. This study investigated the protective effect of licorice water extract against cadmium
(CdCl2, Cd)-induced liver toxicity in rats. To induce acute toxicity, Cd (4mg/kg body weight)
was dissolved in normal saline and intravenously (i.v.) injected into rats. The rats then received
either a vehicle or licorice water extract (50, 100mg/kg/day) for 3 days, and were subsequently
exposed to a single injection of Cd 24h after the last licorice/vehicle treatment. Alanine
aminotransferase (ALT), aspartate aminotransferase (AST) and lactate dehydrogenase (LDH)
were significantly increased by Cd treatment. In contrast, pretreatment with licorice reduced
ALT, AST and LDH. In histopathological analysis, licorice decreased the central necrosis
around central veins, the peripheral hemorrhage around portal triads, the percentage of
degenerative hepatic regions (%/mm
2 hepatic parenchyma) and the number of degenerative
hepatic cells (N/100 hepatic cells). Licorice also inhibited the increment of Bad (a BH3 domain-
containing protein) translocation by Cd in liver cells. These results demonstrate that licorice
could have a hepatoprotective effect by inhibiting the translocation of Bad to the mitochondria
in Cd-intoxificated rats.
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Introduction
Licorice (Glycyrrhizae radix) is one of the oldest and
most frequently used botanical treatments in East Asia.
Licorice has been recommended for its life-enhancing
properties, detoxification and as a cure for digestive
disorders and swelling (1). Herbal medicines containing
licorice have shown stimulatory effects in immune
systems (2,3). Licorice has also been reported to attenuate
free radical-induced oxidative damage in the kidney (4)
and prevent carcinogenesis induced by toxicants
or hormones (5). Licorice contains flavonoids and
pentacyclic triterpene saponins including liquiritigenin,
liquiritin, isoliquiritigenin, liquiritin apioside and glycyr-
rhizin (6). Among these components, glycyrrhizin, which
is the major constituent, comprises 4% to 13% of the
dried root weight (1). Glycyrrhizin has antiviral (7–9),
anticarcinogenic (10,11) and hepatoprotective (12–16)
effects. Liquiritigenin, an aglycone of liquiritin, shows
cytoprotective effects against cadmium (Cd)-induced
toxicity (17) in a rat-derived hepatocyte cell line and
hepatoprotective effects against acute injuries induced by
acetaminophen (18).
There are approximately 35 heavy metals in our
environment. Heavy metals become toxic when they are
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properly cited.not metabolized, which allows them to accumulate in
many organs (19,20). Cd, a common toxic heavy metal,
is widely distributed in the environment due to its use
in industry (21,22). Acute exposure to Cd causes dysuria,
polyuria, chest pain, fatigue and headache (23). Chronic
intake of Cd in contaminated food or air produces
organ dysfunction as a result of cell death, resulting in
pulmonary, hepatic and renal tubular diseases (24).
The liver is the most important target organ when
considering Cd-induced toxicity because Cd primarily
accumulates in the liver (25–27).
We previously reported that licorice-inhibited
Cd-induced toxicity in vitro, therefore in this study, we
tested the effects of licorice in vivo by examining its
protective effects against Cd-induced toxicity in rats.
Methods
Preparation of Licorice Water Extract
Licorice water extract contains high levels of liquiritin,
liquiritin apioside, liquiritigenin, isoliquiritin, isoliquiritin
apioside and glycyrrhizin (6). Licorice water extract was
prepared by boiling 600g of licorice (Wolsung Pharm.,
Daegu, Korea) in 5l C of water for 3h, then filtering the
solution through a 0.2mm syringe filter (Nalgene, USA)
and storing it at  20 C until use. The amount of licorice
water extract was estimated based on its dried weight
after being lypholized. The yield of lyophilized water
extract from licorice was 13%.
Rats
Rat studies were conducted in accordance with the
institutional guidelines for the care and use of laboratory
animals. Six-weeks-old Sprague-Dawley rats (140–160g)
were provided by Hyochang Science (Daegu, Korea) and
acclimatized for 1 week. Rats were caged in an atmo-
sphere of filtered, pathogen-free air, provided with
commercial rat chow (Purina, Korea) and water
ad libitum and maintained at a temperature between 20
and 23 C with a 12h light/dark cycle and relative
humidity of 50%. To induce acute liver injury, Cd
(CdCl2, 4mg/kg body weight) was dissolved in normal
saline and intravenously (i.v.) injected into the rats. This
dose was selected because it severely elevated plasma
alanine aminotransferase (ALT) levels in a previous
experiment that evaluated the hepatoprotective activity
of GdCl3, (28). To evaluate the hepatoprotective effect of
licorice, rats were administrated either a vehicle (tap
water) or licorice water extract (50, 100mg/kg) for 3 days
and subsequently exposed to a single injection of Cd 24h
after the last licorice/vehicle treatment. Tissue and blood
samples were obtained 24h after Cd exposure.
Blood Chemistry
At the end of the experimental period, blood was
collected by means of a heart puncture and serum was
separated by centrifugation. Alanine aminotransferse
(ALT), aspartate aminotransferase (AST) and lactate
dehydrogenase (LDH) in serum, were assayed using an
analysis kit for each respective enzyme according to the
manufacturer’s instructions (Pointe Scientific Inc.,
Canton, MI, USA). Assays were read using an auto-
mated blood chemistry analyzer (Photometer 5010,
Robert Riele GmbH & Co KG, Berlin, Germany).
Histopathology
The left lateral lobe of the liver was sliced (three slices per
rat), and tissue slices were fixed in 10% neutral buffered
formalin for 6h, embedded in a paraplast automatic
tissue processor (Citadel 2000, Shandon Scientific,
Cheshire, UK), sectioned (4mm) and stained with
hematoxylin and eosin (H&E) stain. The percentage of
the degenerative liver region showing central necrosis
and peripheral hemorrhage was calculated using
image analysis (SIS, Germany) under microscopic exam-
ination at 50  magnification (Zeiss, Germany) with the
results expressed as %/mm
2 of hepatic parenchyma.
Additionally, the number of degenerative cells showing
vacuolation or any necrotic process was also calculated
using an automated image analysis under microscopic
examination at 200  magnification and expressed as
N/100 hepatic cells.
Mitochondrial Bad Assay
Under death friendly condition, Bad (a BH3 domain-
containing protein) translocates to mitochondria and
induces apoptosis. To examine the effect of licorice on
apoptosis in liver tissue, Bad protein in mitochondria was
determined by western blot analysis. Mitochondria
isolation was conducted using a mitochondria isolation
kit (Pierce, USA) according to the manufacturer’s
instructions. Briefly, 150–200mg of liver tissue was
subjected to Dounce homogenization on ice, and then
centrifuged after the addition of the mitochondria
isolation reagent provided in the kit. The supernatant
was then centrifuged again at 3000g for 15min at 4 C.
Next, the precipitated mitochondrial pellet was washed
and the protein content analyzed by BCA protein assay.
The expression of Bad was immunochemically monitored
using antimouse Bad antibody (Santa Cruz, USA). Bands
corresponding to Bad and actin were visualized using
ECL western blotting detection reagents (Amersham
Biosciences, USA) according to the manufacturer’s
instructions.
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A one-way analysis of variance procedure was used to
assess significant differences among the treatment groups.
The Newman–Keuls test was used for comparisons of
multiple group means for each treatment for which a
significant effect was observed. The criterion for statis-
tical significance was set at p50.05 or p50.01.
Results
Survival Rates
All control rats were maintained safely for the duration
of the experiment. Rats in the licorice treated groups
showed increased survival rates of 60%, 90% and 100%
when treated with Cd alone, Cd plus 50mg/kg of licorice
and Cd plus 100mg/kg of licorice, respectively (Table 1).
The liver weights of the Cd-treated rats and licorice
treated rats were not significantly different from the
controls (Table 1).
Clinical Chemistry
An increase in liver ALT, AST and LDH indicates liver
damage. The blood biochemistry showed a protective
effect of licorice on Cd-induced liver toxicity. The levels
of ALT, AST and LDH activities in the plasma of rats
were increased 24h after a single Cd treatment. Licorice
pretreatments at a dose of 50mg/kg and 100mg/kg for
three consecutive days inhibited the plasma ALT and
LDH activities in rats challenged with Cd (Table 1).
Licorice at a dose of 100mg/kg reduced the Cd-increased
plasma AST activity (Table 1).
Histopathological Evaluation
To verify the liver protective effects of licorice against
Cd-induced toxicity, the extent of liver damage was
examined histopathologically. Healthy control rats
showed no pathological changes (Fig. 1A, a), however
severe central lobular necrosis around central veins
and peripheral hemorrhage around portal triads was
observed in the livers of Cd-treated rats (Fig. 1A, b).
These Cd-induced histological changes were reduced by
licorice treatment in a dose dependant manner (Fig. 1A, c
and d). The percentage of degenerative hepatic regions
(%/mm
2 hepatic parenchyma) following Cd treatment
was increased to 83.30% compared with the vehicle-
treated control rate of 1.42%. In contrast, these regions
were decreased to 54.62% and 46.07% in the rats treated
with 50mg/kg and 100mg/kg of licorice, respectively
(Fig. 1B). An increased number of degenerative hepatic
cells compared to that of the control samples were also
detected after Cd treatment. The numbers of degenerative
hepatic cells (N/100 hepatic cells) in the control and Cd
treatment groups were 3.67 and 51.50, respectively,
however, the number of cells in the Cd treatment group
was reduced to 36.17 and 32.67 in rats pretreated with
50mg/kg and 100mg/kg of licorice, respectively (Fig. 1B).
Inhibition of Bad Translocation into Mitochondria
by Licorice
Bad is localized in the cytosol under normal conditions.
In the presence of death-inducing stimuli, Bad translo-
cates to mitochondria and binds to Bcl-2, Bcl-xL and
Bcl-w inhibiting their antiapoptotic actions. It pro-
motes apoptosis through the cytochrome c release from
mitochondria (29,30). Thus, mitochondrial translocation
of Bad is an important apoptotic regulatory mechanism.
Previously we reported that cell death, as a result of Cd,
occurred due to apoptosis involving Bad translocation,
and licorice reduced apoptosis by inhibiting translocation
of Bad in hepatocyte cell lines (17). To investigate
this effect of licorice in vivo, we isolated the mitochon-
drial fraction and conducted western blot analysis. As
shown in Fig. 2, we found that Bad translocation into
mitochondria was reduced by licorice.
Discussion
Many toxicants, including chemicals and drugs, induce
liver injuries. Some components of licorice have been
reported to exhibit hepatoprotective activities. CCl4-
induced hepatotoxicity is a common model for screening
hepatoprotective compounds (31). Glycyrrhizin, a major
Table 1. Effects of licorice on the values of ALT, AST and LDH in serum of experimental animals
Treatment Survival rate
y (%) Weight
yy (Liver/Body) ALT (IU/L) AST (IU/L) LDH (IU/L)
Control 100 0.0510 0.00244 111.9 12.6
yyy 228.7 22.9 911.2 229.8
Cd alone 60 0.0488 0.00078 1536.0 279.5* 2739.0 346.0* 8564.0 825.8*
Cdþlicorice (50mg/kg) 90 0.0508 0.00141 845.0 112.0** 2236.0 276.8 4027.7 922.3**
Cdþlicorice (100mg/kg) 100 0.0505 0.00149 510.8 144.9** 1253.5 303.9** 3420.7 1168.9**
y
Survival was recorded 24h after Cd exposure following the consecutive licorice pretreatment for 3 days. Ten rats per group were used at the
beginning.
yyEach liver weight was divided by body weight.
yyyValues represent the mean SE (significantly different from vehicle-treated control,
*p50.01 and significantly different from Cd alone, **p50.01).
eCAM 2009;6(2) 197component of licorice, is a well-known hepatoprotective
compound against CCl4-induced liver injury in rats
(14–16). 18b-Glycyrrhetinic acid, the aglycone found in
glycyrrhizin, is also a potent hepatoprotective compound
in CCl4-induced hepatotoxicity (12,16). Pretreatment with
18b-Glycyrrhetinic acid reduced ALT and AST in serum,
and also reduced hepatic lipid peroxidation caused by
CCl4. Acetaminophen overdose can also induce liver
toxicity through CYP2E1-mediated oxidative metabo-
lism. Accumulation of acetaminophen with buthionine
sulfoximine leads to severe liver injuries that result in
death. Liquiritigenin pretreatment significantly reduced
ALT and LDH activities induced by acetaminophen
with or without buthionine sulfoximine in plasma, and
also reduced liver necrosis in rats (18).
Heavy metals such as cadmium and lead, which are
liver toxicants, are widely distributed in the environment
due to their use in industry. Oxidative stress, an
important mechanism associated with toxic effects of
lead, has been implicated in liver injury associated with
lead (32,33). Cd, one of the most common toxic heavy
metals, can induce and bind to metallothionein, which
concentrates Cd up to 3000-fold (34). Free Cd, which has
not complexed with metallothionein, changes the enzyme
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Figure 1. Inhibition of hepatic injuries in rats pretreated with licorice. Rats were orally pretreated with licorice (50, 100mg/kg body weight for
3 days) and exposed to a single injection of Cd (i.v., 4mg/kg body weight) 24h after the last licorice/vehicle treatment. A) Hepatic histopathology:
The liver sections from healthy control rats (a), Cd alone (b), Cdþlicorice (50mg/kg) (c) and Cdþlicorice (100mg/kg) (d) were stained with H&E
(100  or 200 ). Scale bars¼20mm. B) Percentage of the liver degenerative region showing centrilobular necrosis and peripheral hemorrhage was
calculated as%/mm
2 of hepatic parenchyma. The number of degenerative cells showing vacuolation or any necrotic process was calculated as N/100
hepatic cells. Values represent the mean SE (n¼6, significantly different from vehicle-treated control, **p50.01 and significantly different from
Cd alone,
#p50.05,
##p50.01).
198 Licorice Against Cd-intoxificated Ratsactivity and membrane structure by reacting with the
sulfhydryl group of the membrane, resulting in liver
injury (35). Liqiritigenin showed hepatoprotective effects
against Cd-induced toxicity in a rat-derived hepatocyte
cell line (17) and against acute injuries induced by
acetaminophen (18). Glycyrrhizin is also beneficial
against liver toxicity induced by CCl4 (14–16), lead
acetate (13) and acetaminophen (36). However, glycyr-
rhizin had no protective effects against Cd-induced
hepatotoxicity in rats. Shaikh et al. reported that a
Japanese drug containing glycine, glycyrrhizin and cystein
has hepatoprotective effects against Cd toxicity and the
hepatoprotective effect of this drug is due to glycine
not glycyrrhizin (37). In this study, we confirmed
the hepatoprotective activity of licorice against
Cd-induced toxicity. Based on previous studies, the
reported beneficial effects of licorice may be partially
due to liquiritigenin, not glycyrrhizin, therefore the
protective effects of liquiritigenin on Cd-induced hepato-
toxicity needs to be elucidated.
Upon clinical examination, the increase of ALT and
AST levels in plasma is considered a biomarker of liver
injury (38). When exposed to Cd, the levels of ALT and
AST were usually increased, which indicated liver
injury. LDH is another index of hepatotoxicity, although
the plasma LDH level is relatively insensitive (39). In our
study, licorice significantly reduced Cd-induced ALT,
AST and LDH levels in plasma.
Generally, Cd-induced hepatopathy shows central
lobular necrosis and peripheral hemorrhage (40–42) and
the hepatoprotective effects of various agents have been
evaluated based on these histopathological changes
(43–45). In this study, we confirmed that licorice could
dose-dependently inhibit the severe central lobular
necrosis around central veins and peripheral hemorrhage
around portal triads in Cd-treated rat livers. Licorice
also reduced the percentage of degenerative hepatic
regions (%/mm
2 hepatic parenchyma) and the number
of Cd-increased, degenerative hepatic cells (N/100
hepatic cells).
Oxidative stress is a major cause of Cd-induced
toxicity. Dong et al. reported that toxic metals, such as
CdCl2 and V2O5, stimulate inflammatory cytokines in
hepatocytes through an oxidative stress mechanism (46).
Exposure to CdCl2 leads to a decrease in the activities
of antioxidant enzymes, such as superoxide dismutase
and catalase (47), and to an increase in the activity
of glutathione S-transferase in the liver (48). At the
cellular level, Cd depletes glutathione and protein-bound
sulfhydryl groups, leading to increased lipid peroxidation
and enhanced intracellular oxidized states (49).
In certain pathophysiologic situations, Cd also causes
apoptosis and necrotic cell death. Micromolar Cd induces
apoptosis irrespective of sulfhydryl deficiency, whereas
submolecular Cd, in conjunction with sulfhydryl defi-
ciency, causes non-apoptotic cell death (50). Licorice
and liquiritigenin prevented both apoptotic and non-
apoptotic cell death induced by Cd (10mM) only or Cd
(0.3mM) coupled with buthionine sulfoximine treatments.
Specifically, licorice reduced apoptosis via inhibition
of Bad protein translocation from cytosol to the
mitochondrial membrane (17).
Bad is a pro-apoptotic Bcl-2 protein. That protein
locates in cytosol combined with 14–3–3 protein in live
cells. When the cells go to death program, what we call
apoptosis, the Bad protein is dephosphorylated and
translocates into mitochondrial membrane (29,30).
This translocation of Bad into mitochondria induces
cytochrome c release into cytosol from mitochondria,
and released cytochrome c activates caspase pathway,
an important step in apoptotic cell death. In this study,
mitochondrial Bad was intensively increased by
Cd treatment in vivo, implicating the involvement of
apoptosis in rat liver injuries. However, Bad transloca-
tion into the mitochondria was blocked by licorice.
In conclusion, we clearly confirmed the in vivo
hepatoprotective effects of licorice against Cd-induced
injuries. Inhibition of Bad translocation contributes to
the liver protection afforded by licorice.
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